Late pulmonary sequelae of bronchopulmonary dysplasia

W H Northway1, R B Moss, K B Carlisle

  • 1Department of Diagnostic Radiology and Nuclear Medicine, Stanford University Medical Center, CA 94305.

Insights

Most adults who had bronchopulmonary dysplasia (BPD) as infants experience ongoing lung issues, including airway obstruction and hyperinflation. This study assessed long-term pulmonary function in these individuals.

Area of Science:

  • Pulmonary Medicine
  • Pediatric Pulmonology
  • Neonatology

Background:

  • Bronchopulmonary dysplasia (BPD) is a prevalent chronic lung disease in infants, often resulting from mechanical ventilation for respiratory failure.
  • BPD is the most common chronic lung disease in US infants, but its long-term outcomes remain largely undetermined.
  • Understanding the long-term pulmonary sequelae of BPD is critical for managing affected individuals into adulthood.

Purpose of the Study:

  • To determine the long-term pulmonary function in adolescents and young adults with a history of bronchopulmonary dysplasia in infancy.
  • To compare pulmonary function in individuals with a history of BPD to age-matched control groups.
  • To identify the prevalence and nature of pulmonary dysfunction in this cohort.

Main Methods:

  • Pulmonary function tests were conducted on 26 adolescents and young adults with a history of BPD.
  • A control group of 26 age-matched individuals without mechanical ventilation and 53 normal subjects were included for comparison.
  • Pulmonary function parameters, including FEV1, FEF25-75, MVV, and response to methacholine/bronchodilator, were assessed.

Main Results:

  • 68% of subjects with BPD history exhibited airway obstruction, with significantly reduced FEV1 and FEF25-75 compared to controls (P < 0.0001).
  • Fixed airway obstruction was present in 24%, and reactive airway disease in 52% of subjects with BPD history.
  • Hyperinflation was significantly more frequent in the BPD group (P < 0.0006 vs. matched cohort, P < 0.0004 vs. normal controls).
  • Six subjects (24%) experienced severe pulmonary dysfunction or current respiratory symptoms.

Conclusions:

  • The majority of adolescents and young adults with a history of BPD exhibit persistent pulmonary dysfunction.
  • This dysfunction includes airway obstruction, airway hyperreactivity, and hyperinflation.
  • The long-term clinical implications of this chronic pulmonary dysfunction require further investigation.
Abstract

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...